AI Driven Repositioning and Repurposing Summit 2021
Despite advances in science and technology, denovo drug development has been a costly and time-consuming process over the past decades.
Given these circumstances, drug repositioning and repurposing has appeared as an alternative tool to accelerate drug development processes by seeking new indications for approved/shelved drugs rather than discovering de novo drug compounds.
The newest computational approach to drug repositioning showing the greatest promise is AI and machine learning. With a drug-repurposing strategy, AI can quickly detect drugs that can fight against emerging diseases (such as Covid-19) as well as existing diseases.
The AI Driven Drug Repositioning & Repurposing Summit will bring together 80+ leaders in repurposing
and pioneers in AI and machine learning to strategize how repurposing can reach its full potential to:
• Improve time and cost savings of drug development
• Leverage the safety advantage in reducing development risk
• Unlock market potential advantage
• Improve return on investment for repurposed drugs
• Explore out-licensing options
This meeting aims to help pharma, biotech and academics stay ahead of the curve in their repurposing endeavors during a period exploding with new technologies. Join cutting-edge discussions with the like of AstraZeneca, BenevolentAI, and Healx, to solve ongoing technical challenges surrounding AI tools in repurposing, understand the delicate risk-reward balance in potential repurposing opportunities and explore lessons learned from AI applications in repurposing during Covid-19.
Featuring 2 days of jam-packed content, this digital summit will provide you with all the information you need to begin implementing AI tools into repurposing projects within your organization. What’s more, our digital platform allows you to take part in live Q&A with the presenters, take a tour of the virtual exhibition, and even join online rooms where you can join targeted interactive discussion groups!
Visit our website to find out more.
